CACI International (CACI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

CACI International reported Q4 revenue of $2.3 billion, up 13% year-over-year and slightly exceeding estimates by 0.34%, with EPS of $8.40 significantly beating consensus by 28.44%. Despite these headline beats, key underlying metrics were mixed, including a miss on organic growth and a substantial shortfall in commercial and other customer group revenues, although technology and Department of Defense segments performed strongly. The stock has underperformed the S&P 500 over the past month, returning -3.6%, and holds a Zacks Rank #4 (Sell), signaling potential near-term market underperformance.

Analysis

CACI International (CACI) reported a mixed fourth quarter for fiscal year 2025, characterized by strong headline figures but underlying operational weaknesses. The company posted revenue of $2.3 billion, a 13% year-over-year increase that marginally beat consensus estimates by 0.34%, while earnings per share of $8.40 represented a significant 28.44% surprise over the $6.54 consensus. However, a deeper analysis reveals a more nuanced picture. Total organic revenue growth of 5.3% fell short of the 6% analyst forecast, and the 'Expertise' revenue segment missed expectations. The most significant shortfall occurred in the 'Commercial and other' customer group, which reported $114.43 million against a $206.09 million estimate. These weaknesses were offset by strength in the 'Technology' segment, which grew 19.2% year-over-year to $1.34 billion, and in the core Department of Defense segment, which exceeded revenue estimates. This mixed operational result is contextualized by the stock's recent -3.6% return over the past month, underperforming the S&P 500, and a Zacks Rank of #4 (Sell), indicating potential for near-term underperformance.

Key Decisions for Investors

• Investors should look beyond the significant EPS beat and scrutinize the quality of earnings, given that key metrics like organic growth and commercial revenues missed expectations.
• The outperformance in the core Department of Defense and Technology segments contrasts sharply with weakness elsewhere, suggesting a need to monitor whether strength in government contracts can continue to offset commercial shortfalls.
• Given the stock's recent market underperformance and the explicit Zacks Rank #4 (Sell), a cautious stance is warranted, as these negative signals temper the positive headline earnings report.